437 related articles for article (PubMed ID: 17305535)
1. Silybin and silymarin--new and emerging applications in medicine.
Gazák R; Walterová D; Kren V
Curr Med Chem; 2007; 14(3):315-38. PubMed ID: 17305535
[TBL] [Abstract][Full Text] [Related]
2. Silybin and silymarin--new effects and applications.
Kren V; Walterová D
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2005 Jun; 149(1):29-41. PubMed ID: 16170386
[TBL] [Abstract][Full Text] [Related]
3. Silymarin and Its Role in Chronic Diseases.
Neha ; Jaggi AS; Singh N
Adv Exp Med Biol; 2016; 929():25-44. PubMed ID: 27771919
[TBL] [Abstract][Full Text] [Related]
4. Chirality Matters: Biological Activity of Optically Pure Silybin and Its Congeners.
Křen V
Int J Mol Sci; 2021 Jul; 22(15):. PubMed ID: 34360650
[TBL] [Abstract][Full Text] [Related]
5. Silymarin impacts on immune system as an immunomodulator: One key for many locks.
Esmaeil N; Anaraki SB; Gharagozloo M; Moayedi B
Int Immunopharmacol; 2017 Sep; 50():194-201. PubMed ID: 28672215
[TBL] [Abstract][Full Text] [Related]
6. Metabolism, Transport and Drug-Drug Interactions of Silymarin.
Xie Y; Zhang D; Zhang J; Yuan J
Molecules; 2019 Oct; 24(20):. PubMed ID: 31615114
[TBL] [Abstract][Full Text] [Related]
7. Cell signaling and regulators of cell cycle as molecular targets for prostate cancer prevention by dietary agents.
Agarwal R
Biochem Pharmacol; 2000 Oct; 60(8):1051-9. PubMed ID: 11007941
[TBL] [Abstract][Full Text] [Related]
8. Milk thistle and prostate cancer: differential effects of pure flavonolignans from Silybum marianum on antiproliferative end points in human prostate carcinoma cells.
Davis-Searles PR; Nakanishi Y; Kim NC; Graf TN; Oberlies NH; Wani MC; Wall ME; Agarwal R; Kroll DJ
Cancer Res; 2005 May; 65(10):4448-57. PubMed ID: 15899838
[TBL] [Abstract][Full Text] [Related]
9. Anticancer potential of silymarin: from bench to bed side.
Agarwal R; Agarwal C; Ichikawa H; Singh RP; Aggarwal BB
Anticancer Res; 2006; 26(6B):4457-98. PubMed ID: 17201169
[TBL] [Abstract][Full Text] [Related]
10. Silymarin/Silybin and Chronic Liver Disease: A Marriage of Many Years.
Federico A; Dallio M; Loguercio C
Molecules; 2017 Jan; 22(2):. PubMed ID: 28125040
[TBL] [Abstract][Full Text] [Related]
11. A study of high-dose oral silybin-phytosome followed by prostatectomy in patients with localized prostate cancer.
Flaig TW; Glodé M; Gustafson D; van Bokhoven A; Tao Y; Wilson S; Su LJ; Li Y; Harrison G; Agarwal R; Crawford ED; Lucia MS; Pollak M
Prostate; 2010 Jun; 70(8):848-55. PubMed ID: 20127732
[TBL] [Abstract][Full Text] [Related]
12. Silybin and its congeners: from traditional medicine to molecular effects.
Křen V; Valentová K
Nat Prod Rep; 2022 Jun; 39(6):1264-1281. PubMed ID: 35510639
[TBL] [Abstract][Full Text] [Related]
13. Milk thistle (Silybum marianum): A concise overview on its chemistry, pharmacological, and nutraceutical uses in liver diseases.
Abenavoli L; Izzo AA; Milić N; Cicala C; Santini A; Capasso R
Phytother Res; 2018 Nov; 32(11):2202-2213. PubMed ID: 30080294
[TBL] [Abstract][Full Text] [Related]
14. Silibinin--a promising new treatment for cancer.
Cheung CW; Gibbons N; Johnson DW; Nicol DL
Anticancer Agents Med Chem; 2010 Mar; 10(3):186-95. PubMed ID: 20015009
[TBL] [Abstract][Full Text] [Related]
15. Recapitulation of Evidence of Phytochemical, Pharmacokinetic and Biomedical Application of Silybin.
Islam A; Mishra A; Siddiqui MA; Siddiquie S
Drug Res (Stuttg); 2021 Nov; 71(9):489-503. PubMed ID: 34318464
[TBL] [Abstract][Full Text] [Related]
16. Silymarin and skin cancer prevention: anti-inflammatory, antioxidant and immunomodulatory effects (Review).
Katiyar SK
Int J Oncol; 2005 Jan; 26(1):169-76. PubMed ID: 15586237
[TBL] [Abstract][Full Text] [Related]
17. Silybin, a Major Bioactive Component of Milk Thistle (Silybum marianum L. Gaernt.)-Chemistry, Bioavailability, and Metabolism.
Bijak M
Molecules; 2017 Nov; 22(11):. PubMed ID: 29125572
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of T-cell inflammatory cytokines, hepatocyte NF-kappaB signaling, and HCV infection by standardized Silymarin.
Polyak SJ; Morishima C; Shuhart MC; Wang CC; Liu Y; Lee DY
Gastroenterology; 2007 May; 132(5):1925-36. PubMed ID: 17484885
[TBL] [Abstract][Full Text] [Related]
19. Effects of silymarin flavonolignans and synthetic silybin derivatives on estrogen and aryl hydrocarbon receptor activation.
Plísková M; Vondrácek J; Kren V; Gazák R; Sedmera P; Walterová D; Psotová J; Simánek V; Machala M
Toxicology; 2005 Nov; 215(1-2):80-9. PubMed ID: 16076518
[TBL] [Abstract][Full Text] [Related]
20. The silymarin composition… and why does it matter???
Chambers CS; Holečková V; Petrásková L; Biedermann D; Valentová K; Buchta M; Křen V
Food Res Int; 2017 Oct; 100(Pt 3):339-353. PubMed ID: 28964357
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
